Video
Oxybutynin nets dramatic reduction in hot flashes
SAN ANTONIO – The 6-week reduction in a hot flash score capturing both frequency and severity was about 30% with placebo, 65% with oxybutynin 2.5...
Video
Extent of breast surgery is tied to quality of life among young breast cancer survivors
SAN ANTONIO – Younger breast cancer patients who undergo unilateral or bilateral mastectomy report lower breast satisfaction and poorer...
News
pCR may obviate need for adjuvant chemotherapy
SAN ANTONIO – A meta-analysis finds no added event-free survival benefit from adjuvant chemotherapy among the 21.1% of patients who achieved a pCR...
Video
RT of lymph nodes as good as dissection for the long-term
SAN ANTONIO – Both axillary RT and axillary lymph node dissection provide excellent, comparable locoregional control in patients with early-stage...
Video
Nothing to gain from chemo after pCR achieved
SAN ANTONIO - The only thing women with localized breast cancer who achieve a pCR after neoadjuvant chemo may gain from further chemo from...
Video
Small absolute difference between partial and whole breast irradiation
SAN ANTONIO – A phase 3 trial was unable to rule out the possibility that, after lumpectomy, partial breast irradiation is inferior to whole...
News
Adjuvant capecitabine found disappointing in TNBC
SAN ANTONIO – A phase 3 trial was negative, showing that adding adjuvant capecitabine to surgery and chemotherapy does not improve survival in...
Video
No boost in OS with addition of capecitabine for early TNBC
SAN ANTONIO – Adding adjuvant capecitabine to surgery and standard chemotherapy did not improve disease-free or overall survival in women with...
News
Study reveals long-term survival in MM patients
A retrospective study suggests one in seven patients with newly diagnosed multiple myeloma (MM) who are eligible for transplant may live at least...
News
New data further support curability of myeloma
A study has found that a sizable share of transplant-eligible patients can expect to live as long as similar people in the general population.
News
Valve-in-valve TAVR benefits maintained at 3 years
SAN DIEGO – Improvements in heart failure functional class and quality of life after valve-in-valve TAVR are maintained out to at least 3 years....
News
Tumor burden in active surveillance for mRCC may inform treatment decisions
An Italian retrospective cohort study has found that tumor burden more consistently predicted survival than IMDC risk class and number of...
News
Transcatheter repair for tricuspid regurgitation holds up at 1 year
SAN DIEGO – The procedure reduced regurgitation to mild or moderate levels in nearly four-fifths of patients.
News
BIOFLOW V: Orsiro outperforms Xience stent
San Diego – Two-year results of the BIOFLOW V randomized head-to-head comparison show superiority was driven by a lower rate of target vessel–...